Toxicities of CAR T-Cell Therapy: Beyond CRS and Neurotoxicity
The information presented in this talk will address the long-term effects of CAR T-cell therapy, including HLH/MAS, B-cell aplasia, and prolonged cytopenias. Nurses will learn how to recognize signs/symptoms of these effects and how to manage them in order to educate patients and provide ideal care to patients undergoing CAR T-cell therapy.
Category
  • Acute Lymphoblastic Leukemia
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Updates in the Treatment of CNS Cancers
The involvement of an interdisciplinary team in the treatment of patients with CNS cancers is a key factor for appropriate management. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice, and research in this area is ongoing.
Category
  • CNS Cancers
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Communicating an Adult Diagnosis of Cancer to Children
Nurses are a valuable resource to support and guide parents in communicating their cancer diagnosis with their children. This can result in improved relationships, better coping and less stress on the parent. With the proper training, nurses can facilitate this process while supporting and empowering parents in sharing this personal experience with their children.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Developing Oncofertility Program for Pre-Pubertal, Adolescent, and Young Adult Patients
With continued education, nurses can feel more empowered in having these tough conversations with their patients and improve the quality of care provided.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: CAR-T Therapy in Multiple Myeloma
Pharmacists should be aware of the new data and recommendations surrounding this novel agent and how they relate to improvements in patient survival and quality of life. It is also important to be aware of the potential for unique and potentially severe adverse events that can occur with these therapies.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Best Practices for Genetic Risk Assessment and Counseling
The field of cancer genetics has implications for all aspects of cancer management of individuals with hereditary or familial cancers, including prevention, screening, and treatment. A management plan based on genetic test results should only be developed for identified pathogenic or likely pathogenic variants that are clinically actionable.
Category
  • Genetic/Familial High-Risk Assessment
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Liver-Directed and Systemic Therapy Options for Hepatocellular Carcinoma
Incidence and mortality rates for most cancers are declining; however, the incidence and mortality rates for liver cancer are increasing. A thorough understanding of the different approaches to treatment can help clinicians identify the optimal treatment strategy. Keeping clinicians abreast of new developments in the field can better inform clinical decision-making.
Category
  • Hepatobiliary Cancers
  • Hepatocellular Carcinoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Plenary Session – The Patient Journey: Access to Cancer Care
This session will focus on how quality cancer care is now available closer to your home, or even in your home. To ensure safe access to cancer care, it is important for those who manage patients with cancer and those with responsibility for patient access to recognize how cancer care has evolved over the last few years and to review current challenges and recommendations for continued improvement in patient access to quality cancer care in the future.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Locoregional Management of Patients with Early-Stage Breast Cancer
Locoregional management strategies have evolved over the years. In order to define clinical situations that require appropriate locoregional therapies and use the right approach, clinicians need to stay current on the updates and controversies.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
New Treatment Options for Patients with Bladder Cancer
A number of new treatment options for different stages of bladder cancer are on the horizon, which will make education about the data behind these therapies and how they might be used in clinical practice important. Of interest, a number of treatment options for bacillus Calmette Guérin (BCG)-unresponsive non–muscle invasive bladder cancer (NMIBC) are currently being evaluated in clinical trials, and systemic therapy options for muscle-invasive and metastatic disease have rapidly expanded.
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages